# ORQO V2 — Phase 15 Implementation Report

**Status: Phase 15 COMPLETE — PASS (Company & Opportunity Intelligence).** The work is local on `phase-15-company-opportunity-intelligence` and has not been pushed or deployed. There is no schema change, and Production and ORQO Test are unchanged by Phase 15.

Contracts, decisions and Phase 16 integration points are in `PHASE-15-HANDOFF.md`.

## Delivered
- **Partnership Scenario Engine:** 15 reviewed mechanisms, selected by both companies' Business DNA traits.
- **New-offering hypotheses:** joint offer and co-development, always labelled "ORQO-generated hypothesis".
- **Deal Critic:** falsifying, evidence-triggered, and able to reject.
- **Revenue hypotheses:** who pays, for what and how. No amounts.
- **Company Intelligence 2.0 dossier:**
  - executive assessment and why it matters;
  - needs (inference or hypothesis) and why now (dated evidence, or unknown);
  - the decisive question and the next investigation;
  - discarded ideas and the target's market.
- **Domain-adaptive Search relevance:**
  - the dossier replaces the hardware-shaped block on Search;
  - the Phase 11 physical-product rules are now a trait-gated specialization on the Network and event pages.
- **Own profile:** the own company's typed profile counts as user-stated Business DNA.
- **Deal Intelligence Report:** built from stored intelligence only, with browser print-to-PDF.
- **Deferred by owner decision:** Founder / Internal entitlement (Phase 17).

## Validation (final regression, run once)
| Check | Result |
|---|---|
| Unit (`bun run test`) | **508 pass, 0 fail** (38 files); Phase 15 adds 18 |
| Typecheck · Lint · Production build | Pass · Pass (0 problems) · Pass |
| DB / RLS (ORQO Test) | **193 pass, 0 fail** (13 files) |
| HTTP (ORQO Test) | **53 pass, 1 skip, 0 fail** (54). The skip is the existing opt-in live-AI test |
| E2E `e2e:app` | Pass (25 screens, no console errors). Dossier `ready`, with contract production and embedding (both credible). The report opened without creating any research run. The print view hides the navigation |
| E2E `e2e:network`, `e2e:discover`, `e2e:agents`, `e2e:understanding` | Pass |

## Cross-domain validation (fictional pairs)
| Pair | Result |
|---|---|
| Manufacturer × hardware company | Contract production (decisive question: production model; timing from a dated launch) |
| SaaS × SaaS | Technical integration, evidence-backed. No production, fulfilment or licensing |
| Consultancy × SaaS | Implementation and referral. No product distribution |
| Biotech × pharma | Licensing (licence and royalties), with the regulatory constraint stated |
| Logistics × consumer brand | Fulfilment, evidence-backed |
| Niche company | Zero scenarios; "read your company" or "learn the target" |
| Two hauliers | No business, "similarity only" |

The critic **rejects** contract production when the partner is confirmed to manufacture itself.

## INFODIP × GigaIO (read-only, stored Dev data)
**Inputs:** INFODIP's stored typed profile and GigaIO's stored intelligence. There was no fetch and no write.

**Result:**
| Scenario | Label | Verdict and basis |
|---|---|---|
| Technical integration | Evidence-backed | Credible, with dated partnership timing |
| Implementation partnership | Evidence-backed | Credible |
| Contract production by INFODIP | Hypothesis | Credible, but "need not shown" |

**Decisive questions:** "Do shared customers ask for the two products to work together?" and "Does GigaIO produce in-house or outsource its production?"

There is no company-specific code. The only change for this case was vocabulary data: "ODM" was added to the manufacturer-role terms.

## Security and cost
- **No provider:** no provider call and no new authority, action, agent, entitlement or write. Static guards cover the engine, dossier and report.
- **Tenancy:** RLS keeps the evidence tenant-scoped (DB test). The report requires sign-in (HTTP test) and never researches (static test, plus the E2E research-run count).
- **Unchanged:** paid providers forced off in all isolated runs; `.env.local` unchanged.
